Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 7/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.60 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.59 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.55 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.53 |
| ▸ | CASP2 | P42575 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | CNR2 | P34972 | 1/20 | 0.49 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26491481 | 1.00 | FAAH (0.64) | FAAHMEN1MAPK1KMT2AEPHX1 | |
| SCHEMBL20876854 | 1.00 | FAAH (0.64) | FAAHMEN1MAPK1KMT2AEPHX1 | |
| SCHEMBL1457445 | 1.00 | FAAH (0.64) | FAAHMEN1MAPK1KMT2AEPHX1 | |
| SCHEMBL8372916 | 1.00 | FAAH (0.64) | FAAHMEN1MAPK1KMT2AEPHX1 | |
| Tetrahydropellitorine SCHEMBL4878046 | 1.00 | FAAH (0.64) | FAAHMEN1MAPK1KMT2AEPHX1 | |
| SCHEMBL20883256 | 1.00 | FAAH (0.64) | FAAHMEN1MAPK1KMT2AEPHX1 | |
| SCHEMBL7432688 | 1.00 | FAAH (0.64) | FAAHMEN1MAPK1KMT2AEPHX1 | |
| SCHEMBL1456461 | 1.00 | FAAH (0.64) | FAAHMEN1MAPK1KMT2AEPHX1 | |
| SCHEMBL9462479 | 0.98 | FAAH (0.61) | FAAHMEN1MAPK1KMT2AEPHX1 | |
| Hydrochloric Acid SCHEMBL5396087 | 0.96 | FAAH (0.59) | FAAHMEN1MAPK1KMT2AEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 408 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3691645-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING DELAYED RELEASE GELLING AGENT COMPOSITIONS | Purdue Pharma L.P. (US) | 2020-08-12 | — | — | EP | claimed |
| WO-2019070581-A1 | PHARMACEUTICAL COMPOSITIONS COMPRISING DELAYED RELEASE GELLING AGENT COMPOSITIONS | PURDUE PHARMA L.P (US) | 2019-04-11 | — | — | WO | claimed |
| US-20190046522-A1 | PHARMACEUTICAL FORMULATION CONTAINING IRRITANT | PURDUE PHARMA LP (US) | 2019-02-14 | — | — | US | claimed |
| US-10028947-B2 | Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent | PURDUE PHARMA L.P. (US) | 2018-07-24 | — | — | US | claimed |
| US-10022369-B2 | Pharmaceutical formulation containing irritant | PURDUE PHARMA L.P. (US) | 2018-07-17 | — | — | US | claimed |
| EP-2900272-B1 | ABUSE DETERRENT PHARMACEUTICAL COMPOSITION COMPRISING KONJAC GLUCOMANNAN | PHARMASCIENCE INC (CA) | 2018-06-06 | — | — | EP | claimed |
| US-20180117158-A1 | Abuse Deterrent Pharmaceutical Composition | PHARMASCIENCE INC. (CA) | 2018-05-03 | — | — | US | claimed |
| US-20170354654-A1 | PHARMACEUTICAL FORMULATION CONTAINING OPIOID AGONIST, OPIOID ANTAGONIST AND IRRITANT AGENT | PURDUE PHARMA LP (US) | 2017-12-14 | — | — | US | claimed |
| US-20170296671-A1 | Tamper Resistant Pharmaceutical Formulations | PURDUE PHARMA LP (US) | 2017-10-19 | — | — | US | claimed |
| US-20170173000-A1 | PHARMACEUTICAL FORMULATION CONTAINING IRRITANT | PURDUE PHARMA LP (US) | 2017-06-22 | — | — | US | claimed |
| US-20070014732-A1 | Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant agent | PURDUE PHARMA L.P. (US) | 2007-01-18 | — | — | US | claimed |
| US-7157103-B2 | Pharmaceutical formulation containing irritant | EURO-CELTIQUE S.A. (LU) | 2007-01-02 | — | — | US | claimed |
| JP-2005501067-A | — | — | 2005-01-13 | — | — | JP | claimed |
| EP-1414413-A1 | COMPOSITIONS AND METHODS TO PREVENT ABUSE OF OPIOIDS | Euro-Celtique S.A. (LU) | 2004-05-06 | — | — | EP | claimed |
| EP-1414418-A1 | COMPOSITIONS AND METHODS TO PREVENT ABUSE OF OPIOIDS | Euro-Celtique S.A. (LU) | 2004-05-06 | — | — | EP | claimed |
| US-20030068370-A1 | Pharmaceutical formulation containing irritant | PURDUE PHARMA L.P. | 2003-04-10 | — | — | US | claimed |
| US-20030068392-A1 | Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant | PURDUE PHARMA L.P. | 2003-04-10 | — | — | US | claimed |
| WO-2003013476-A1 | COMPOSITIONS AND METHODS TO PREVENT ABUSE OF OPIOIDS | EURO-CELTIQUE S.A. (LU) | 2003-02-20 | — | — | WO | claimed |
| WO-2003013479-A1 | COMPOSITIONS AND METHODS TO PREVENT ABUSE OF OPIOIDS | EURO-CELTIQUE S.A. (LU) | 2003-02-20 | — | — | WO | claimed |
| EP-0546078-B1 | BIRDFOOD CONTAINING CAPSAICIN OR ITS DERIVATIVES OR ANALOGUES | US HEALTH (US) | 1999-02-24 | — | — | EP | claimed |